A cluster analysis demonstrated the potential for the Multiple Sleep Latency Test (MSLT) to aid in the diagnosis of central hypersomnia and distinguish between idiopathic hypersomnia subgroups. The ...

MSLT testing is performed to rule out sleep disorders known as Narcolepsy and will measure the extent of a patient’s daytime sleepiness. This test is usually conducted during the day, following a ...

— Orexin 2 Receptor Agonist ALKS 2680 Demonstrated Clinically Meaningful and Statistically Significant Improvements from Baseline in Mean Sleep Latency Compared to Placebo at All Doses Tested — — ALKS ...

Think you may have excessive daytime sleepiness? Check in with your doctor, and keep these seven questions in mind to help find out the cause of your symptoms. Excessive daytime sleepiness, or ...

Excessive daytime sleepiness can make it hard to concentrate, drive, and do routine tasks. It may happen even after a full night’s rest. Possible causes include sleep disorders like insomnia, sleep ...

CHICAGO -- Novel orexin receptor 2 agonist oveporexton normalized wakefulness for most people with narcolepsy type 1 in two randomized phase III trials. Mean sleep latency across four, 40-minute ...

A study investigating potential subtypes of idiopathic hypersomnia (IH) found that patients with IH who experience unrefreshing naps have less fragmented sleep compared with those who take refreshing ...